A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
References (32)
- et al.
Why do some people go blind from glaucoma?
Ophthalmology
(1982) - et al.
Intraocular pressure and progression of glaucomatous visual field loss
Am J Ophthalmol
(2000) - et al.
Influence of surgical reduction of intraocular pressure on regions of the visual field with different levels of sensitivity
Am J Ophthalmol
(2001) - et al.
Target pressure-glaucomatologists' holey grail
Ophthalmology
(2000) - et al.
Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open angle glaucoma: A randomized, controlled, investigatorblinded study
Clin Ther
(2004) - et al.
Compliance with ocular therapy
Surv Ophthalmol
(1980) - et al.
Travoprost compared with latanoprost and timolol in patients with open-angle glauco ma or ocular hypertension
Am J Ophthalmol
(2001) Interim report: National Registry of possible drug-induced ocular side effects
Ophthalmology
(1980)- et al.
Ocular beta-blockers and systemic effects
Am J Ophthalmol
(1984) - et al.
Additive intraocular pressure lowering effect of various medications with latanoprost
Am J Ophthalmol
(2002)
A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma
Am J Ophthalmol
(1986)
The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
Am J Ophthalmol
(1998)
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration
Am J Ophthalmol
(2000)
Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial
Arch Ophthalmol
(2002)
The Ocular Hypertension Treatment Study: Design and baseline description of the participants
Arch Ophthalmol
(1999)
Cited by (50)
Reply to Comment on: Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
2020, American Journal of OphthalmologyEffect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma
2019, American Journal of OphthalmologyA Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%
2016, American Journal of OphthalmologyAlpha Agonists
2015, Glaucoma: Second EditionPropranolol Transport Across the Inner Blood-Retinal Barrier: Potential Involvement of a Novel Organic Cation Transporter
2013, Journal of Pharmaceutical SciencesHow latanoprost changed glaucoma management
2024, Acta Ophthalmologica
Copyright © 2006 Published by Elsevier Inc.